Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

MYSTERIOUS: Dexcom earnings preview what to expect | Mind Blowing Facts

Valued at a market cap of $25.5 billion, DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems. The San Diego, California-based company’s products help patients, caregivers, and healthcare professionals manage diabetes and broader metabolic health conditions in real time. It is expected to announce its fiscal Q3 earnings for 2025 after the market closes on Thursday, Oct. 30.

Before this event, analysts expect this medical device company to report a profit of $0.57 per share, up 26.7% from $0.45 per share in the year-ago quarter. The company has surpassed Wall Street’s bottom-line estimates in two of the last four quarters, while missing on two other occasions. Its earnings of $0.48 per share in the previous quarter topped the consensus estimates by 6.7%. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.